Results 231 to 240 of about 5,114,489 (264)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of biochemical and molecular toxicology, 2022
Zoledronic acid, a nitrogen‐containing bisphosphonate drug, is used for the treatment of osteoporosis, Paget's disease of bone, and tumor‐induced osteolysis.
M. Kara +5 more
semanticscholar +1 more source
Zoledronic acid, a nitrogen‐containing bisphosphonate drug, is used for the treatment of osteoporosis, Paget's disease of bone, and tumor‐induced osteolysis.
M. Kara +5 more
semanticscholar +1 more source
ACS Nano, 2021
Radiation therapy can potentially elicit a systemic immune response and cause the regression of nonirradiated tumors, and the checkpoint blockade immunotherapies have been introduced to improve their clinical response rate.
Zhusheng Huang +8 more
semanticscholar +1 more source
Radiation therapy can potentially elicit a systemic immune response and cause the regression of nonirradiated tumors, and the checkpoint blockade immunotherapies have been introduced to improve their clinical response rate.
Zhusheng Huang +8 more
semanticscholar +1 more source
American Journal of Sports Medicine, 2020
Background: Bone mineral density at the humeral head is reduced in patients with chronic rotator cuff tears. Bone loss in the humeral head is associated with repair failure after rotator cuff reconstruction. Bisphosphonates (eg, zoledronic acid) increase
J. Schanda +11 more
semanticscholar +1 more source
Background: Bone mineral density at the humeral head is reduced in patients with chronic rotator cuff tears. Bone loss in the humeral head is associated with repair failure after rotator cuff reconstruction. Bisphosphonates (eg, zoledronic acid) increase
J. Schanda +11 more
semanticscholar +1 more source
Differences between zoledronic acid and denosumab for breast cancer treatment
Journal of Bone and Mineral Metabolism, 2023Takashi Ishikawa
semanticscholar +1 more source